Status:

TERMINATED

ANET Electrosurgery Applicator Pilot Evaluation Study

Lead Sponsor:

Olympus Corporation of the Americas

Conditions:

Lung Cancer

Lung Cancer Metastatic

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Evaluate the preliminary safety and performance of the Electrosurgery Applicator (ANET device) during and after bronchoscopic ablation of a target pulmonary nodule/tumor.

Detailed Description

This study is a prospective, single arm, single center study that will evaluate the effectiveness of the ANET Electrosurgery Applicator in up to 10 subjects. Subjects who consent to participate in th...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Subject with Stage I or Stage II primary lung cancer or metastatic lung tumor
  • Pathological proof of target nodule/tumor type and malignancy
  • Target nodule/tumor which can be accessed via EBUS bronchoscopy
  • Resection/surgical candidate
  • Participants must be at least 18 years old and able to provide consent
  • Exclusion criteria:
  • Subjects in whom flexible bronchoscopy is contraindicated
  • Target nodule \< 1.0 cm
  • Prior radiation or neo adjuvant chemotherapy of the target nodule/tumor
  • Any comorbidity that the investigator feels would interfere with the safety of the subject or the evaluation of study objectives
  • Pacemaker, implantable cardioverter, or other electronic implantable device

Exclusion

    Key Trial Info

    Start Date :

    April 23 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 18 2020

    Estimated Enrollment :

    6 Patients enrolled

    Trial Details

    Trial ID

    NCT03400748

    Start Date

    April 23 2018

    End Date

    November 18 2020

    Last Update

    April 3 2024

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States, 02215

    2

    Duke University Medical Center

    Durham, North Carolina, United States, 27710

    3

    UT MD Anderson Cancer Center

    Houston, Texas, United States, 77030

    4

    Toronto General Hospital

    Toronto, Ontario, Canada, M5G 2C4